State of Wyoming - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.

Quarter-by-quarter ownership
State of Wyoming ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$430,550
-25.3%
41,801
+19.6%
0.09%
-44.6%
Q2 2023$576,124
+133.8%
34,959
+29.9%
0.17%
+112.7%
Q1 2023$246,431
+18.2%
26,903
-7.6%
0.08%
+14.5%
Q4 2022$208,428
+65.4%
29,110
+15.9%
0.07%
+11.3%
Q3 2022$126,000
+293.8%
25,109
+91.6%
0.06%
+210.0%
Q2 2022$32,00013,1030.02%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders